Antibiotic prevents irritable bowel syndrome symptoms for weeks after final dose

A targeted antibiotic provides effective and long-lasting relief of irritable bowel syndrome symptoms, according to the results of two multisite Phase III clinical trials. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug.

Read the whole article on Science Daily

More from Science Daily